Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Oncology|June 25, 2021
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated TherapiesMaria B Garcia-Fabiani, Santiago Haase, Andrea Comba, et al.
Research Square|May 7, 2026
Extrachromosomal DNA Gives Cancer a New Evolutionary PathwayElizabeth Brunk, Yue Wang, Oliver Cope, et al.
The Journal of Clinical Investigation|December 17, 2020
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in micePadma Kadiyala, Stephen V Carney, Jessica C Gauss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote RadioresistanceStephen V Carney, Kaushik Banerjee, Anzar Mujeeb, et al.
The Journal of Clinical Investigation|September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma modelsSantiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
Science Advances|September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapyMahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
Science Translational Medicine|February 15, 2019
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage responseFelipe J Núñez, Flor M Mendez, Padma Kadiyala, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric GliomasMaria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.
Pageof 3